Judy Keen, PhD, is an accomplished scientific leader known for forging innovative partnerships across the pharmaceutical industry, non-profits, medical associations, and technology companies to accelerate the integration of emerging science and digital medicine into clinical oncology. With a career spanning academia, government, non-profit organizations, and the pharmaceutical sector, Judy brings a uniquely comprehensive perspective to tackling complex healthcare challenges.
Dr. Keen earned her Bachelor of Science in Biology from Gettysburg College, followed by a Master of Science from the Krieger School of Arts and Sciences at Johns Hopkins University. She went on to earn a PhD in Environmental Health Science from the Johns Hopkins Bloomberg School of Public Health and completed a Postdoctoral Fellowship in breast cancer research at the Johns Hopkins School of Medicine.
Prior to her current role, Judy served as Director of Cancer Translational Science at the Foundation for the National Institutes of Health, where she led public-private collaborations to address critical gaps in oncology care. She also held leadership positions across a range of sectors, consistently advancing scientific innovation and public health impact.
In addition to her new role as CEO of the American Society for Bone and Mineral Research (ASBMR), headquartered in Silver Spring, Maryland, Judy is actively engaged in academic and professional service. She serves as First Vice President of the Johns Hopkins Alumni Association, Chair of the Advisory Board of Johns Hopkins University Press, and a member of the Advisory Board for the Environmental Engineering program at both the Johns Hopkins Whiting School of Engineering and the Bloomberg School of Public Health.
Dr. Keen’s career reflects a steadfast commitment to advancing science through collaboration and driving meaningful change at the intersection of innovation, policy, and patient care.
